The pps is going up not down... insiders must know that the 'investigations' have turned up fruitless classic short tactic here and everyone that has done their dd knows it plus add in the political moves by the pharm mfgs that stand to lose a ton to this new technology
IBIO has technology that is far beyond the ebola bubble, just so happened that the ebola buzz has put the spotlight on this and helped to position IBIO for license/buyout of their intellectual property method for advanced med production with lower capital requirements and accelerated time to market along with drastically increased production volume capabilities... (see their website for specifics)
this is why it is a good fit for ebola too since the current method is costly, time consuming and extremely low annual dose creation.
ebola aside, this company is about to explode in cash